Watchlist Price Alert

CollPlant Biotechnologies... (CLGN)

NASDAQ: CLGN · Real-Time Price · USD

2.06

0.01 (0.49%)

At close: Jun 06, 2025, 10:12 AM

CollPlant Biotechnologies Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	515K	10.96M	299K	15.64M	6.14M	2.32M	4.79M	479.92K	75.91K
Cost of Revenue	1.63M	1.99M	400K	2M	3M	1.88M	378.63K	14.96K	225.07K
Gross Profit	-1.11M	8.97M	-101K	13.64M	3.13M	439K	4.41M	464.96K	-149.16K
Operating Income	-17.25M	-7.51M	-17.1M	65K	-5.6M	-7.63M	-4.07M	-5.97M	-7.16M
Interest Income	738K	788K	321K	219K	40K	10K	438.11K	72.79K	n/a
Pretax Income	-16.61M	-7.02M	-16.93M	237K	-5.77M	-11.16M	-3.69M	-6.01M	-7.25M
Net Income	-16.61M	-7.02M	-16.75M	409K	-5.81M	-14.7M	-6.25M	-6.05M	-7.24M
Selling & General & Admin	5.63M	6M	6.74M	5.94M	4.67M	3.62M	3.29M	2.38M	2.86M
Research & Development	10.52M	10.48M	10.26M	7.63M	4.07M	4.41M	5.16M	4.05M	4.36M
Other Expenses	n/a	n/a	n/a	n/a	n/a	33K	21.51K	13.52K	9.88K
Operating Expenses	16.14M	16.48M	17M	13.57M	8.73M	8.07M	8.48M	6.44M	7.24M
Interest Expense	17K	10K	34K	37K	34K	63K	15.13K	21.58K	33.48K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	48K	n/a	n/a	n/a	n/a
Cost & Expenses	17.77M	18.47M	17.4M	15.58M	11.74M	9.95M	8.85M	6.45M	7.24M
Income Tax Expense	n/a	n/a	-172K	-172K	34K	3.53M	2.96M	28.44K	-86.28K
Shares Outstanding (Basic)	11.45M	11.39M	11.03M	9.97M	6.89M	4.99M	4.38M	2.66M	2.01M
Shares Outstanding (Diluted)	11.45M	11.39M	11.03M	11.97M	6.89M	4.99M	4.38M	2.66M	2.01M
EPS (Basic)	-1.45	-0.62	-1.52	0.04	-0.84	-2.95	-1.43	-2.27	-3.6
EPS (Diluted)	-1.45	-0.62	-1.52	0.03	-0.84	-2.95	-1.43	-2.27	-3.6
EBITDA	-16.21M	-6.41M	-16.02M	838K	-4.94M	-7.09M	-3.9M	-5.73M	-6.95M
EBIT	-17.25M	-7.51M	-17.1M	65K	-5.6M	-7.63M	-4.25M	-5.96M	-7.16M
Depreciation & Amortization	1.04M	1.1M	1.08M	773K	660K	539K	342K	291.63K	225.07K